Silver Book Fact

Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.

Philipson T, Eber M, Lakdawalla D, Corral M, et al. An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer. Health Affairs. 2012; 31(4): 667-75. http://content.healthaffairs.org/content/31/4/667.abstract

Reference

Title
An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer
Publication
Health Affairs
Publication Date
2012
Authors
Philipson T, Eber M, Lakdawalla D, Corral M, et al.
Volume & Issue
Volume 31, Issue 4
Pages
667-75
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Cervical cancer screening reduces incidence by over 80%.  
  • Colorectal Cancer Screening: Trends, 2003-2006  
  • A modest 1% reduction in cancer mortality would be worth close to $500 billion. A cure for cancer (if one is feasible) would be worth around $50 trillion.  
  • The 5-year survival rate for prostate cancer has increased from 67% to nearly 100% over the past 20 years.  
  • Gains in healthy years of life and social value from cancer R&D